PharmiWeb Recruiter Blog

• Collaboration leverages HotSpot's Smart Allostery™ drug discovery platform for the development of the first and only small molecule IRF5 (interferon regulatory factor 5) inhibitor for the potential treatment of autoimmune diseases
• HotSpot to receive an upfront cash payment of $40 million with potential for further milestones and royalties

NORTH CHICAGO, Ill. and BOSTON, Dec. 6, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) and HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases, today announced an exclusive worldwide collaboration and option to license agreement for HotSpot's discovery-stage IRF5 program for the treatment of autoimmune diseases.

New collaborative project involving 15 large pharma companies will support diversity in executive roles and advocate a fairer working culture with more equal opportunities.

Berkshire, UK, December 5th, 2022. PharmiWeb.Jobs, Europe’s largest dedicated Life Science job board, is pleased to announce its new partnership with the Pharmaceutical Contract Management Group (PCMG), a unique association of Outsourcing and Procurement professionals working in Research and Development functions across the pharmaceutical industry.

Research & Development (R&D) jobs are the most in-demand across the Life Sciences sector with vacancies up 5% year-on-year. That’s according to new research from the Association of Professional Staffing Companies (APSCo), the trade association for the professional staffing sector.

At work, less than 18% of people use a time management system, and 1 in 8 never feel in control of their work. With the Life Science industry demanding more from recruiters and hiring managers every day, now is the time to review how your time is currently being spent, and implement new techniques to help you stay productive and motivated at work.

Bagsværd, Denmark, 22 November 2022 – Novo Nordisk today announced plans to invest 5.4 bn Danish kroner in the expansion of existing facilities in Bagsværd. The plans also include the construction of a new plant located in extension of the existing facilities.

RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an approximate total equity value of $1.35 billion.

Research by Pharmaceutical Technology found that in the 2021-2022 reporting year, 95.7% of pharmaceutical companies with a headcount above 250 pay their male employees higher than their female employees. The same research found that across the pharmaceutical industry, median hourly pay was 10% higher for males than females, placing the industry below the UK average of 11.6%.

New Integrated Clinical Site Organization Led by World-Class Clinical Development Experts

London, U.K., 17 November 2022: Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announces its expansion into the U.K. with the acquisition of multi-site company Egin Research.